The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Single-institution experience using transarterial chemoembolization (TACE) with carboplatinum (carbo) and doxorubicin in patients (pts) with hepatocellular carcimona (HCC) awaiting liver transplantation (LTx).
Bradley Alan Switzer
Disclosure not yet available
Katherine Harvey
Disclosure not yet available
Steven R. Grossman
Disclosure not yet available
David A. Phillips
Disclosure not yet available
Shimul A. Shah
Disclosure not yet available
Adel Bozorgzadeh
Disclosure not yet available
Bilal Piperdi
Disclosure not yet available